PLX PHARMA INC (PLXP) Stock Earnings & Estimates
USA - NASDAQ:PLXP - US72942A1079 - Common Stock
0.087 USD
-0.03 (-27.8%)
0.083 USD
0 (-4.6%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 570K -24.00% | 30K -94.74% | 8.208M 27,260.00% | 3.774M -54.02% | 3.57M -5.41% | |
| EBITDA YoY % growth | -14.04M -30.48% | -13.34M 4.99% | -40.674M -204.90% | N/A | N/A | |
| EBIT YoY % growth | -14.2M -29.56% | -13.46M 5.21% | -40.79M -203.05% | N/A | N/A | |
| Operating Margin | -2,491.23% | -44,866.67% | -496.95% | N/A | N/A | |
| EPS YoY % growth | -2.50 -2,372.73% | -1.85 26.00% | -2.22 -20.00% | -1.42 36.14% | -1.12 20.86% |
All data in USD
| Q4 / 22 | |
|---|---|
| EPS Q2Q % growth | -0.29 -385.60% |
| Revenue Q2Q % growth | 714K -55.15% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.30 62.50% | -0.45 | 0.15 | 33.16% |
| Q2 2022 Q2Q % growth | -0.43 45.57% | -0.57 | 0.14 | 24.72% |
| Q1 2022 Q2Q % growth | -0.39 46.58% | -0.74 | 0.35 | 47.14% |
| Q4 2021 Q2Q % growth | 0.10 111.49% | -0.73 | 0.83 | 113.72% |
| Q3 2021 Q2Q % growth | -0.80 -100.00% | -0.47 | -0.33 | -69.03% |
| Q2 2021 Q2Q % growth | -0.79 -19.70% | -0.22 | -0.57 | -257.46% |
| Q1 2021 Q2Q % growth | -0.73 -1,012.50% | -0.22 | -0.51 | -235.48% |
| Q4 2020 Q2Q % growth | -0.87 -248.00% | -0.30 | -0.57 | -194.12% |
| Q3 2020 Q2Q % growth | -0.40 -544.44% | -0.43 | 0.03 | 7.73% |
| Q2 2020 Q2Q % growth | -0.66 40.00% | -0.42 | -0.24 | -55.92% |
| Q1 2020 Q2Q % growth | 0.08 106.45% | -0.40 | 0.48 | 119.86% |
| Q4 2019 Q2Q % growth | -0.25 | -0.49 | 0.24 | 48.94% |
| Q3 2019 Q2Q % growth | 0.09 | -0.50 | 0.59 | 117.83% |
| Q2 2019 Q2Q % growth | -1.10 | -0.44 | -0.66 | -147.92% |
| Q1 2019 Q2Q % growth | -1.24 | -0.34 | -0.90 | -268.39% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 386K -94.17% | 1.326M | -940K | -70.89% |
| Q2 2022 Q2Q % growth | 483K | 3.604M | -3.121M | -86.60% |
| Q1 2022 Q2Q % growth | 2.083M | 2.584M | -501K | -19.39% |
| Q4 2021 Q2Q % growth | 1.592M | 2.088M | -496.1K | -23.76% |
| Q3 2021 Q2Q % growth | 6.616M | 4.182M | 2.434M | 58.20% |
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | 30K -83.33% | 30K | % | |
| Q1 2020 Q2Q % growth | -100.00% | % | ||
| Q4 2019 Q2Q % growth | 20K | 13.597K | 6.403K | 47.10% |
| Q3 2019 Q2Q % growth | 40K | 60.18K | -20.18K | -33.53% |
| Q2 2019 Q2Q % growth | 180K | 113.22K | 66.78K | 58.98% |
| Q1 2019 Q2Q % growth | 320K | 102.683K | 217.317K | 211.64% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |